News

智通財經
2025.09.19 23:21
法拉第未來：FF 與納斯達克上市公司 Qualigen Therapeutics, Inc.今日聯合宣佈，雙方已簽署證券購買協議，FF 將通過私募配售投資 QLGN 的普通股和優先股，並將全面合作開展加密及 Web3 業務。 在完成股東批准程序後，QLGN 將更名為 CXC10，全面聚焦於加密業務和 Web3 生態建設 “三駕馬車” 業務。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.